Cytomaton
PrivateCompany Overview
Cytomaton is a biotechnology software company that provides a cloud-native, AI-assisted platform for flow cytometry data analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
flow cytometry analysisautomated gatingflow cytometrybioinformatics softwarecytometry softwaregating automationcloud-native SaaSspectral cytometrybio-saasAI-assisted researchdata reproducibilitylab automationbiotech analyticsscientific softwarelab tech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytomaton Comparables
Compare Cytomaton with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astrolabe Diagnostics | 82% | |
| AHEAD Medicine | 82% | |
| Danaher Corporation | 77% | |
Cytomaton Funding Rounds
Historical fundraising activity
Cytomaton Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cytomaton's valuation, stock price, and market status.
See something wrong or outdated?